Division of Nephrology and Hypertension, Department of Internal Medicine.
Division of Infectious Disease, Department of Internal Medicine, Inha University School of Medicine, Incheon, Korea.
Kidney Res Clin Pract. 2013 Jun;32(2):81-3. doi: 10.1016/j.krcp.2013.04.004. Epub 2013 May 22.
Pseudomonas stutzeri is a Gram-negative, rod-shaped, motile, single polar-flagellated, soil bacterium that was first isolated from human spinal fluid and is widely distributed in the environment. It was isolated as an uncommon opportunistic pathogen from humans, and a few cases of P. stutzeri-induced peritonitis have been reported in patients undergoing continuous ambulatory peritoneal dialysis (CAPD). Catheter removal with antibiotic treatment is generally recommended because peritonitis by Pseudomonas species is commonly associated with catheter-related infection. Here, we describe the first case of P. stutzeri-induced peritonitis in an 82-year-old woman in Korea. She had received two antipseudomonal antibiotics, an aminoglycoside (isepamicin, Yuhan corporation, Seoul, Korea) and a fluoroquinolone (ciprofloxacin), and was successfully treated without removal of the CAPD catheter.
施氏假单胞菌是一种革兰氏阴性、杆状、能动、单极生鞭毛的土壤细菌,最初从人脊髓液中分离出来,广泛分布于环境中。它是一种从人类中分离出来的不常见的机会致病菌,有少数几例施氏假单胞菌引起的腹膜炎的病例报告发生在接受持续非卧床腹膜透析(CAPD)的患者中。一般建议在使用抗生素治疗的同时去除导管,因为假单胞菌引起的腹膜炎通常与导管相关的感染有关。在这里,我们描述了首例在韩国发生的 82 岁女性施氏假单胞菌引起的腹膜炎病例。她接受了两种抗假单胞菌抗生素治疗,一种氨基糖苷类(异帕米星,Yuhan 公司,首尔,韩国)和一种氟喹诺酮类(环丙沙星),并且在不去除 CAPD 导管的情况下成功治疗。